画面の調整
Resize out
Resize in
Resize リセット
Done 終わった
CureVac - Ingmar Hoerr, CEO

CureVac - Ingmar Hoerr, CEO

1,215 回見ました

人間の検証

8.1
ありがとうございます、あなたの投票が記録され、すぐに表示されます。
はい
いいえ
動画の説明

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

コメント